The development of GIST is attributed to mutations in major oncogenes such as KIT and PDGFRA, which activate downstream signaling pathways, including MAPK, PI3K/AKT, and STAT3 pathways [1]. The gene discussed is PDGFRA; the disease is gastrointestinal stromal tumor.